ArticleJournal for immunotherapy of cancer2022

CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype.

Han Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.